Ian D. Schnadig, MD
Tigard, OR 97223
Compass Oncology - West Cancer Center
12123 Southwest 69th Avenue, Tigard, OR 97223
About Ian D. Schnadig
Dr. Schnadig specializes in genitourinary (GU) malignancies and general oncology and treats benign and malignant hematology. He is very active in The US Oncology Research Network, serving as a member of the national GU Research Committee and as principal investigator for many Phase II and Phase III studies. As GU Chair of the US Oncology Pathways Task Force, he is responsible for developing GU cancer treatment guidelines for physicians nationally. These facts speak to Dr. Schnadig's practice philosophy of applying the most current and innovative thinking to help patients choose therapies and clinical trials targeted to their specific tumor characteristics. Despite this busy schedule, Dr. Schnadig finds time to enjoy the pleasures of Pacific Northwest living including cycling, running and camping. He enjoys spending time with his wife and two children and volunteers at his children's school.
Oregon Health & Science University School of Medicine
2008
Oregon Health & Science University School of Medicine
2003
Rush University Medical Center
2002
Oregon Health & Science University School of Medicine
2005
- Chief Medical Officer, Compass Oncology
- Prostate Cancer Physician Advocate Volunteer for US Too International
- Site Principal Investigator, ECOG Trials, Legacy Health
- Member, US Oncology GU National Research Committee
- GU Chair, Pathways Task Force, Pharmacy and Therapeutics Committee, McKesson
- American Society of Clinical Oncology (ASCO)
- American Society of Hematology (ASH)
- Southwest Oncology Group (SWOG)
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
Providence Willamette Falls Medical Center
Providence St. Vincent Medical Center